Drug Shortage Report for SANDOZ DILTIAZEM T
| Report ID | 59528 |
| Drug Identification Number | 02245920 |
| Brand name | SANDOZ DILTIAZEM T |
| Common or Proper name | DILTIAZEM |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED PRE MARKET |
| Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
| Strength(s) | 240MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100S |
| ATC code | C08DB |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-08-01 |
| Estimated end date | Unknown |
| Actual end date | 2023-07-26 |
| Shortage status | Resolved |
| Updated date | 2023-11-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-11-17 | French | Compare |
| v3 | 2023-11-17 | English | Compare |
| v2 | 2018-08-29 | French | Compare |
| v1 | 2018-08-29 | English | Compare |
Showing 1 to 4 of 4